Clinical trials · New York
Children clinical trials in New York
We’re tracking 198 recruiting children studies with a site in New York — including Phase 1, Phase 1/Phase 2, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies in New York
- NCT06555965Recruiting
STXBP1 and SYNGAP1 natural history study
This study follows people with STXBP1 or SYNGAP1 gene changes over time to learn more about how these conditions affect the body and mind. It does not test a treatment but helps researchers understand the natural course of the disorder.
New York, New YorkAges Any age - NCT06597019RecruitingPhase 3
Study of inclisiran for children with high cholesterol
This trial tests a medicine called inclisiran to lower high cholesterol in children ages 6 to 12 with a genetic condition called heterozygous familial hypercholesterolemia (HeFH). It may help children who still have high cholesterol despite taking other treatments.
New York, New YorkAges 6–11 - NCT04509050Recruiting
Testing a highly effective CF medicine in young children
This study looks at how well a highly effective cystic fibrosis (CF) medicine works in infants and young children, and what biological changes it causes. It may help families understand whether the medicine improves CF function and related measures early in life.
Buffalo, New YorkAges Up to 10 years - NCT06668805RecruitingPhase 2
Testing vosoritide for children with Noonan syndrome and slow growth
This study tests a medication called vosoritide for children with Noonan syndrome who are still growing slowly despite using human growth hormone. The goal is to see if vosoritide can help them grow taller.
New York, New YorkAges 3–11 - NCT07048574Recruiting
Mood and behavior in children with cystic fibrosis
This study looks at mood and behavior in children with cystic fibrosis (CF) under 12. By following children over time, researchers hope to better understand and help with depression, anxiety, and behavior challenges that may come up.
Buffalo, New YorkAges 1.5 years–11 years - NCT07012044RecruitingPhase 1
Cedazuridine and decitabine after stem cell transplant for childhood leukemia
This trial tests if adding two chemotherapy drugs (cedazuridine and decitabine) along with a growth factor (filgrastim) can help prevent leukemia from coming back after a stem cell transplant. It is for children and young adults with high-risk acute myeloid leukemia who are in remission after transplant.
New York, New YorkAges Up to 21 years - NCT06712875RecruitingPhase 1/Phase 2
Brain cancer drug combo for kids with BRAF mutations
This trial tests a combination of targeted therapy (dabrafenib and trametinib) and immunotherapy (nivolumab) for children and young adults with certain BRAF gene changes in their glioma. It aims to see if this drug combination can shrink tumors or stop them from growing.
New York, New YorkAges 1–26 - NCT06740630RecruitingPhase 3
A chickenpox vaccine study for healthy toddlers 12 to 15 months old
This study tests an experimental chickenpox vaccine to see how well it works and if it's safe. Your child may be able to join if they are healthy and between 12 and 15 months old.
The Bronx, New YorkAges 1 year–1.3 years - NCT06921993Recruiting
Study: Using Ultrasound to Guide Antibiotic Use in Childhood Pneumonia
This study tests if lung ultrasound can help doctors decide whether to use antibiotics for children with pneumonia. If your child has signs of pneumonia but is stable enough for an ultrasound, this could help avoid unnecessary antibiotics.
New York, New YorkAges 3–10 - NCT06924307Recruiting
Parent-Child thinking skills program for ages 2-5
This trial tests a program for parents and their young children (ages 2-5) to help improve the child's thinking and self-control skills. It's designed for children without major physical or developmental challenges.
New York, New YorkAges 2–5 - NCT06995729RecruitingPhase 1
Testing zavegepant nasal spray in children with migraines
This trial tests whether the medicine zavegepant (given as a nasal spray) is safe and works well for children aged 6 to 11 who have a history of migraines. If your child gets migraines, this study may help find a new treatment option.
Port Jefferson Station, New YorkAges 6–11 - NCT07029828RecruitingPhase 3
Long-term study of ritlecitinib for severe alopecia areata in children
This study tests a medicine called ritlecitinib for children with severe alopecia areata (a condition causing hair loss). It is for kids who have already completed a previous study of this medicine to see how well it works and how safe it is over a longer period.
The Bronx, New YorkAges 6–14 - NCT07092280Recruiting
Brain stimulation study for children with autism
This trial tests if mild electrical stimulation applied to the head (tDCS) can help children with autism. Your child must be enrolled in ABA therapy and be off certain medications to join.
Staten Island, New YorkAges 5–12 - NCT07092540Recruiting
Baby Duchenne Study: Early Years in Boys With DMD
This study tracks development and health in young boys with Duchenne muscular dystrophy during the first three years of life. It aims to better understand early signs and how the condition progresses, which may help improve care and future treatments.
Rochester, New YorkAges birth–3 years - NCT07114510Recruiting
Best breathing methods during cardiac arrest
This trial compares different ways to give breaths using a breathing tube during CPR to find the best approach for people having a cardiac arrest in the hospital.
New Hyde Park, New YorkAges 9 months–18 years - NCT07116031RecruitingPhase 2
Belumosudil for children with chronic GVHD
This study tests a new medicine called belumosudil for children with chronic graft-versus-host disease (GVHD) that hasn't improved with at least 2 other treatments. The goal is to see if it can help control the disease and improve symptoms.
New York, New YorkAges 1–18 - NCT07188805RecruitingPhase 3
Finerenone for children with heart failure
This study tests a new medicine called finerenone (a pill) to see if it helps children with heart failure who have a weak pumping heart. It compares finerenone to a placebo (a pill with no medicine) while both groups continue their usual heart treatments.
New York, New YorkAges 6 months–17 years - NCT07192952RecruitingPhase 3
Long-term safety of finerenone in children and young adults with heart failure
This study tests the long-term safety of the drug finerenone when taken alongside standard heart failure treatments in children and young adults with weakened heart pumping function (left ventricular systolic dysfunction). It includes both children already in a related study and new infants under 6 months old.
New York, New YorkAges Up to 18 years - NCT07214480Recruiting
Speech therapy for children who struggle with the /s/ sound
This study tests a treatment program for children aged 7 to 11 who have trouble saying the /s/ sound. It's done over Zoom with a computer, and researchers will check if the therapy helps improve their speech.
Syracuse, New YorkAges 7–11 - NCT07216430RecruitingPhase 2
Safety and efficacy of a pneumococcal vaccine in young kids
This study tests a new pneumococcal vaccine (wSp) in young children who have already had 3 doses of a standard pneumococcal shot. It aims to see if the new vaccine is safe and works well to protect against serious infections.
Rochester, New YorkAges 5 months–7 months - NCT07223021RecruitingPhase 3
Fludarabine dosing study for B-cell ALL
This study tests a different dose of the chemotherapy drug fludarabine before CAR T-cell therapy (tisagenlecleucel) for children and young adults with B-cell acute lymphoblastic leukemia. The goal is to see if the new dose works better at helping the body accept the CAR T cells while keeping side effects manageable.
New York, New YorkAges 1 year+ - NCT07300267RecruitingPhase 1
Study of a new pneumococcal vaccine for infants and toddlers
This trial tests a new vaccine called V118C to protect children against pneumococcal disease. It is for two age groups: toddlers aged 12-15 months who already had 3 doses of a standard pneumococcal vaccine, and babies about 2 months old who have not had any pneumococcal vaccine yet.
East Syracuse, New YorkAges 2 months–1.3 years - NCT05131685Recruiting
Child wrist fracture study comparing treatment for certain breaks
This study looks at treatment for children’s wrist (distal radius) fractures that are very displaced but not involving the growth plate. It may help doctors find the best way to reset and stabilize the bone when the fracture is recent.
New York, New YorkAges 4–10 - NCT01885767Recruiting
Neurofibromatosis registry for NF1, NF2, and Schwannomatosis
This trial is a patient registry portal for people diagnosed with neurofibromatosis types NF1, NF2, or schwannomatosis. By joining, you help researchers collect real-world information that may guide future studies and care.
New York, New YorkAges Any age
Children trials by city in New York
Where these studies are running in New York
Institutions with a site for the recruiting children studies listed above.
- Memorial Sloan Kettering Cancer Center · 4 studies
- Children's Hospital at Montefiore · 3 studies
- Columbia University Irving Medical Center · 3 studies
- Mount Sinai Health System · 3 studies
- Icahn School of Medicine at Mount Sinai · 2 studies
- Bay Creek Pediatrics
- Child Health Care Associates
- Children's Hospital of New York
What taking part in a children study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Children trials in other states
Common questions
- Are there children clinical trials in New York?
- Yes. We're currently tracking 198 recruiting children studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a children study in New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a children trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New children studies open in New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.